Clinical Trials Logo

Clinical Trial Summary

To communicate with the observer and guide his gaze on the canvas, painters have developed different stylistic processes that artists, in the manner of scientists, have acquired on the functioning of human visual perception. This direct communication between the artist and the observer is strongly impacted for people with visual impairments.

In order to improve the accessibility and autonomy of visually impaired people in museums and to allow each observer to feel the visual and emotional experience closest to the original work of the artist, it is essential to identify the modifications. perceptive generated by the constriction of vision


Clinical Trial Description

In this experiment, the investigators study the adaptive strategies developed by people with retinitis pigmentosa in the perception of figurative works of art. Peripheral vision is crucial for detecting objects and directing attention to the relevant areas of the environment, while central vision, of high spatial resolution, is especially essential for identifying the nature of objects. The integration of perceived information in peripheral vision and central vision makes it possible to quickly and effortlessly develop a spatial representation of the environment, to activate categorical knowledge on the observed scene and to relate the various objects perceived. However, with the progressive constriction of the visual field, the visual exploration of the subject RP can not be carried out with the strategies used by the healthy subjects, in which the targets of the saccades are in particular determined according to the information perceived in peripheral vision.

Through the recording of eye movements, the investigators compare the differences in visual explorations of people with retinitis pigmentosa and healthy people with or without a simulated deficit. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04360291
Study type Observational
Source Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Contact Tania RILCY
Phone +33 140021126
Email trilcy@15-20.fr
Status Recruiting
Phase
Start date November 4, 2019
Completion date October 17, 2021

See also
  Status Clinical Trial Phase
Completed NCT05179460 - A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy
Recruiting NCT05643157 - Cellular Scale Measures of Short-Term Retinal Atrophy Progression
Recruiting NCT04419285 - Mobility Protocol Adapted for Advanced Visually Impaired Subjects N/A
Recruiting NCT03510234 - Self-confidence Study in Patients With Argus II Artificial Retina